[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

NO317747B1 - Farmasoytisk preparat samt anvendelse derav - Google Patents

Farmasoytisk preparat samt anvendelse derav

Info

Publication number
NO317747B1
NO317747B1 NO19983812A NO983812A NO317747B1 NO 317747 B1 NO317747 B1 NO 317747B1 NO 19983812 A NO19983812 A NO 19983812A NO 983812 A NO983812 A NO 983812A NO 317747 B1 NO317747 B1 NO 317747B1
Authority
NO
Norway
Prior art keywords
pct
date aug
pharmaceutical preparation
sec
active principles
Prior art date
Application number
NO19983812A
Other languages
English (en)
Other versions
NO983812D0 (no
NO983812L (no
NO317747B3 (no
Inventor
Andre Bernat
Jean-Marc Herbert
Pierre Savi
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9489354&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO317747(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of NO983812D0 publication Critical patent/NO983812D0/no
Publication of NO983812L publication Critical patent/NO983812L/no
Publication of NO317747B1 publication Critical patent/NO317747B1/no
Publication of NO317747B3 publication Critical patent/NO317747B3/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A61K31/621—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/36—Antigestagens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Materials For Medical Uses (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO19983812A 1996-02-19 1998-08-19 Farmasoytisk preparat samt anvendelse derav NO317747B3 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9602027A FR2744918B1 (fr) 1996-02-19 1996-02-19 Nouvelles associations de principes actifs contenant un derive de thieno(3,2-c)pyridine et un antithrombotique
PCT/FR1997/000296 WO1997029753A1 (fr) 1996-02-19 1997-02-17 Nouvelles associations de principes actifs contenant du clopidogrel et un antithrombotique

Publications (4)

Publication Number Publication Date
NO983812D0 NO983812D0 (no) 1998-08-19
NO983812L NO983812L (no) 1998-10-09
NO317747B1 true NO317747B1 (no) 2004-12-13
NO317747B3 NO317747B3 (no) 2011-10-03

Family

ID=9489354

Family Applications (2)

Application Number Title Priority Date Filing Date
NO19983812A NO317747B3 (no) 1996-02-19 1998-08-19 Farmasoytisk preparat samt anvendelse derav
NO2010015C NO2010015I2 (no) 1996-02-19 2010-07-09 Klopidogrel og acetylsalicylsyre eller famasøytiskaksepterbare salter derav

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO2010015C NO2010015I2 (no) 1996-02-19 2010-07-09 Klopidogrel og acetylsalicylsyre eller famasøytiskaksepterbare salter derav

Country Status (29)

Country Link
US (1) US5989578A (no)
EP (1) EP0881901B1 (no)
JP (1) JP3662028B2 (no)
KR (1) KR100295345B1 (no)
CN (1) CN1116042C (no)
AT (1) ATE218870T1 (no)
AU (1) AU715655B2 (no)
BR (1) BR9707556A (no)
CA (1) CA2246289C (no)
CZ (1) CZ292363B6 (no)
DE (2) DE122010000030I2 (no)
DK (1) DK0881901T3 (no)
EE (1) EE03513B1 (no)
ES (1) ES2176684T3 (no)
FR (1) FR2744918B1 (no)
HK (1) HK1017850A1 (no)
HU (1) HU225036B1 (no)
IL (1) IL125848A (no)
IS (1) IS1892B (no)
NO (2) NO317747B3 (no)
NZ (1) NZ331444A (no)
PL (1) PL187292B1 (no)
PT (1) PT881901E (no)
RU (1) RU2184547C2 (no)
SI (1) SI0881901T1 (no)
SK (1) SK284285B6 (no)
TR (1) TR199801608T2 (no)
UA (1) UA51695C2 (no)
WO (1) WO1997029753A1 (no)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2322824A1 (en) * 1998-03-13 1999-09-16 Merck & Co., Inc. Combination therapy and composition for acute coronary ischemic syndrome and related conditions
DE69926750T2 (de) 1998-06-17 2006-06-29 Bristol-Myers Squibb Co. Vorbeugung des hirninfarkts durch kombinierte verabreichung von adp-rezeptor antiblutplättchen und antihypertensiven medikamenten
US6509348B1 (en) 1998-11-03 2003-01-21 Bristol-Myers Squibb Company Combination of an ADP-receptor blocking antiplatelet drug and a thromboxane A2 receptor antagonist and a method for inhibiting thrombus formation employing such combination
FR2792836B3 (fr) 1999-04-30 2001-07-27 Sanofi Sa Composition pharmaceutique sous forme unitaire contenant de l'aspirine et de l'hydrogenosulfate de clopidogrel
FR2797400A1 (fr) * 1999-08-11 2001-02-16 Sanofi Synthelabo Associations a activite anti-thrombotique constituees de l'hydrogenosulfate de clopidogrel et d'un antagoniste des recepteurs gpiib/iiia et les compositions pharmaceutiques les contenant
CA2432644C (en) 2000-12-25 2013-07-23 Fumitoshi Asai Pharmaceutical composition comprising aspirintm and cs-747
SE0101932D0 (sv) * 2001-05-31 2001-05-31 Astrazeneca Ab Pharmaceutical combinations
FR2832929A1 (fr) * 2001-12-05 2003-06-06 Sanofi Synthelabo Compositions pharmaceutiques contenant un agent antithrombotique et un derive d'amines cycliques
US20040067995A1 (en) * 2002-10-02 2004-04-08 Wong Pancras C. Novel combination of a factor Xa inhibitor and clopidogrel
US20070243632A1 (en) * 2003-07-08 2007-10-18 Coller Barry S Methods for measuring platelet reactivity of patients that have received drug eluting stents
US7790362B2 (en) * 2003-07-08 2010-09-07 Accumetrics, Inc. Controlled platelet activation to monitor therapy of ADP antagonists
HUP0400982A2 (en) * 2004-05-17 2006-08-28 Chemor Kutato New veterinary product for honeybees
US20060222640A1 (en) * 2005-03-29 2006-10-05 Boehringer Ingelheim International Gmbh New pharmaceutical compositions for treatment of thrombosis
EP1926736A4 (en) * 2005-09-21 2010-08-25 Chong Kun Dang Pharm Corp NEW RESINATE COMPLEX OF S-CLOPIDOGREL AND METHOD FOR THE PRODUCTION THEREOF
WO2008048083A1 (es) * 2006-10-17 2008-04-24 Espinosa Abdala Leopoldo De Je Composiciones farmacéuticas para el tratamiento de enfermedades tromboembólicas
DE102006051625A1 (de) 2006-11-02 2008-05-08 Bayer Materialscience Ag Kombinationstherapie substituierter Oxazolidinone
CN101686681B (zh) 2007-04-27 2015-04-01 锡德克斯药物公司 包含氯吡格雷和磺基烷基醚环糊精的制剂和其使用方法
JP2011512406A (ja) * 2008-02-22 2011-04-21 ハナル バイオファーマ カンパニー リミテッド 複合製剤
DE102008032361A1 (de) 2008-07-10 2010-01-21 Csl Behring Gmbh Der Einsatz von Faktor VIII und vWF bzw. vWF-enthaltenden Konzentraten zur Therapie der durch Thrombocyten-Inhibitoren induzierte Koagulopathie
KR101991367B1 (ko) * 2009-05-13 2019-06-21 사이덱스 파마슈티칼스, 인크. 프라수그렐 및 사이클로덱스트린 유도체를 포함하는 약학 조성물 및 그의 제조 및 사용 방법
NZ597510A (en) 2009-06-25 2012-12-21 Tetra Sia NOVEL ACETYLSALICYLIC ACID SALTS, the salts are 4-trimethylammoniobutanoate, L-carnitine and meldonium
US8563574B2 (en) 2009-12-07 2013-10-22 Academic Pharmaceuticals, Inc. Parenteral formulation of clopidogrel
CN102389436A (zh) * 2011-09-09 2012-03-28 北京阜康仁生物制药科技有限公司 一种抗血小板聚集的药物组合物
KR101675501B1 (ko) * 2011-11-02 2016-11-14 한국유나이티드제약 주식회사 클로피도그렐 및 아스피린의 복합제제
US8513278B2 (en) 2011-11-26 2013-08-20 Academic Pharmaceuticals, Inc. Parenteral dextrose formulation of clopidogrel
CN102406938A (zh) * 2011-11-29 2012-04-11 北京阜康仁生物制药科技有限公司 一种抗血栓的药物组合物
WO2013133620A1 (en) * 2012-03-09 2013-09-12 Yuhan Corporation Pharmaceutical composition comprising clopidogrel and aspirin and process for preparing the same
CN103720700A (zh) * 2012-10-10 2014-04-16 江苏威凯尔医药科技有限公司 含有阿斯匹林和维卡格雷的药用组合物
EP2796145B1 (en) 2013-04-22 2017-11-01 CSL Ltd. A covalent complex of von willebrand factor and faktor viii linked by a disulphide bridge
KR101502588B1 (ko) 2013-05-01 2015-03-16 한국유나이티드제약 주식회사 클로피도그렐 및 아스피린의 복합제제
WO2015015062A1 (fr) * 2013-08-02 2015-02-05 Sanofi Comprime pharmaceutique comprenant de l'acide acetylsalicylique et du clopidogrel
HUP1400294A2 (hu) 2014-06-13 2015-12-28 Skillpharm Kft Clopidogrel új alkalmazása
CN107698620A (zh) 2015-06-23 2018-02-16 江苏天士力帝益药业有限公司 一种氘代噻吩并哌啶衍生物、制备方法及其应用
RU2745774C1 (ru) * 2020-08-14 2021-03-31 Алексей Викторович Марочков Способ лечения пациентов с новой коронавирусной инфекцией (covid-19)
WO2023012479A1 (en) 2021-08-03 2023-02-09 Liqmeds Worldwide Limited An oral pharmaceutical solution of clopidogrel

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2307538A1 (fr) * 1975-04-18 1976-11-12 Centre Etd Ind Pharma Nouveau medicament anti-agregant plaquettaire

Also Published As

Publication number Publication date
EP0881901B1 (fr) 2002-06-12
DE122010000030I2 (de) 2012-06-21
CN1116042C (zh) 2003-07-30
WO1997029753A1 (fr) 1997-08-21
CA2246289C (fr) 2003-12-16
KR100295345B1 (ko) 2001-08-07
ATE218870T1 (de) 2002-06-15
SK110598A3 (en) 1999-01-11
EE9800247A (et) 1999-02-15
AU1884497A (en) 1997-09-02
JPH11510818A (ja) 1999-09-21
PL327923A1 (en) 1999-01-04
EE03513B1 (et) 2001-10-15
CN1211922A (zh) 1999-03-24
HUP9901144A3 (en) 2001-04-28
TR199801608T2 (xx) 1998-11-23
DK0881901T3 (da) 2002-10-07
IS1892B (is) 2003-10-20
DE69713287D1 (de) 2002-07-18
NO2010015I2 (no) 2012-11-12
HUP9901144A2 (hu) 1999-09-28
IL125848A (en) 2000-11-21
RU2184547C2 (ru) 2002-07-10
NO983812D0 (no) 1998-08-19
UA51695C2 (uk) 2002-12-16
PL187292B1 (pl) 2004-06-30
ES2176684T3 (es) 2002-12-01
IS4827A (is) 1998-08-18
FR2744918A1 (fr) 1997-08-22
CZ249998A3 (cs) 1998-11-11
BR9707556A (pt) 1999-07-27
DE122010000030I1 (de) 2010-10-21
PT881901E (pt) 2002-09-30
NO983812L (no) 1998-10-09
CZ292363B6 (cs) 2003-09-17
HK1017850A1 (en) 1999-12-03
HU225036B1 (en) 2006-05-29
SK284285B6 (sk) 2005-01-03
CA2246289A1 (fr) 1997-08-21
NO2010015I1 (no) 2010-07-26
US5989578A (en) 1999-11-23
NZ331444A (en) 2001-04-27
FR2744918B1 (fr) 1998-05-07
NO317747B3 (no) 2011-10-03
JP3662028B2 (ja) 2005-06-22
KR19990087163A (ko) 1999-12-15
EP0881901A1 (fr) 1998-12-09
IL125848A0 (en) 1999-04-11
AU715655B2 (en) 2000-02-10
DE69713287T2 (de) 2002-12-19
SI0881901T1 (en) 2002-10-31

Similar Documents

Publication Publication Date Title
NO317747B1 (no) Farmasoytisk preparat samt anvendelse derav
RS50485B (sr) Terapeutske kombinacije koje sadrže amplodipin i atorvastatin
ID28003A (id) Turunan-turunan adamantana
HUP0000737A2 (hu) Hialuronsav mikrorészecskékbe foglalt hatóanyagokat tartalmazó nyújtott hatóanyagleadású készítmény
EP0828485A4 (en) USE OF THE R-ENANTIOMER OF N-PROPARGYL-1-AMINOINDANE, ITS SALTS AND COMPOSITIONS
IT8323205A0 (it) Composizioni farmaceutiche adattivita' antiinfiammatoria e/o analgesica, non ulcerogene.
ZA9811445B (en) Aminobiguanides and the use thereof to disinfect contact lenses and preserve pharmaceutical compositions.
PT101444A (pt) Associacao sinergizante com efeito antagonista dos receptores nk1 e nk2, uso de produtos com actividade antagonista dos receptores nk1 e nk2 na sua preparacao e composicao farmaceutica contendo a referida associacao
PT862575E (pt) Novos derivados de geranilgeranilo processo para a sua preparacao e composicoes farmaceuticas relacionadas
EE200100051A (et) Vastavast (-)-stereoisomeerist põhiliselt vaba (+)-nortsisapriidi või selle farmatseutiliselt vastuvõetava soola kasutamine ja farmatseutiline kompositsioon
BR9506956A (pt) Composição farmacêutica antitussígena
HU9802886D0 (en) Substituted heterocyclic benzocycloalkenes and their use as analgetic active ingredients
ZA949874B (en) B3-adrenergic agents, benzodioxole dicarboxylates and their use in pharmaceutical compositions.
NO985807D0 (no) Transdermale systemer inneholdende 2 aktive ingredienser i separate seksjoner, deres fremstillingsprosess og deres anvendelse som medikament
MX9709453A (es) Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion.
BG101849A (en) Bicyclic tachyquinine antagonists, their preparation and use in pharmaceutical compositions
BG106151A (en) Pharmaceutical complex
HUP9903619A2 (hu) 5HT2c Antagonistát és D2 antagonistát tartalmazó gyógyszerkészítmény
GB9802542D0 (en) New use
TW333453B (en) Pharmaceutical composition comprising toremifene for use in the treatment of autoimmune diseases
KR960033451A (ko) 나트륨 치환 트립토판을 포함하는 b형 간염 치료제
ITMI951210A0 (it) Nuovi derivati dell'alfa-tocoferolo e composizioni farmaceutiche che li contengono quali principi attivi

Legal Events

Date Code Title Description
SPCF Filing of supplementary protection certificate

Free format text: PRODUCT NAME: SAMMENSETNINGEN AV KLOPIDOGREL OG ACETYLSALICYLSYRE (ASPIRIN) ER PRODUKTET AV STOFFENE DUOPLAVIN OG DUOCOVER. KLOPIDOGREL OG ACETYLSALICYLSYRE OMFATTES I.A. AV GRUNDPATENTETS KRAV 1. SE OGSA THE MERCK INDEX; NAT. REG. NO/DATE: EU/1/10/619/001/NO 20100323; FIRST REG. NO/DATE: EU/1/10/619/001-014 20100315

Spc suppl protection certif: 2010015

Filing date: 20100709

LC4 Limitation of patent rights - b3 (par. 39b patent act)

Effective date: 20111003

SPCG Granted supplementary protection certificate

Free format text: PRODUCT NAME: SAMMENSETNINGEN AV KLOPIDOGREL OG ACETYLSALICYLSYRE (ASPIRIN) ER PRODUKTET AV STOFFENE DUOPLAVIN OG DUOCOVER. KLOPIDOGREL OG ACETYLSALICYLSYRE OMFATTES I.A. AV GRUNDPATENTETS KRAV 1. SE OGSA THE MERCK INDEX; NAT. REG. NO/DATE: EU/1/10/619/001/NO 20100323; FIRST REG. NO/DATE: EU/1/10/619/001-014 20100315

Spc suppl protection certif: 2010015

Filing date: 20100709

Extension date: 20220217

MK1K Patent expired